Bruce Willis kicked out of store for ‘refusing’ to wearing mask – WGHP FOX 8 Greensboro

ARKANSAS (KNWA/KFTA) — Johnson & Johnson is close to wrapping up data analysis for Phase 3 of its COVID-19 vaccine trial.

Janssen, the Belgian unit pharmaceutical division of Johnson & Johnson, reported approximately 45,000 people have participated in Phase 3 clinical trials, also known as ENSEMBLE, as of December. Participants were recruited for the third phase at the end of September after data from Phase 1 and 2 was completed, according to the Global Head of Research & Development at Janssen Mathai Mammen.